All lobbying filings

Miller Strategies, LLC

Miller Strategies, LLC filed a Q3 report for Pharmaceutical Research and Manufacturers of America on October 20, 2026, reporting $60,000 in lobbying income.

Lobbying for Pharmaceutical Research and Manufacturers of America · represents biopharmaceutical research companies

As filed: MILLER STRATEGIES, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA.

All filings by Miller Strategies, LLC · Everything Pharmaceutical Research and Manufacturers of America has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medicare/Medicaid

Medicare and healthcare policy issues as they relate to drug pricing, CMMI, and Medicare Part D; including rebate system reforms

Foreign Relations

Issues related to COINS Act implementation.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.